Neumora Therapeutics Inc (NMRA) Unusual Options Activity Today

Checking NMRA unusual options activity helps you spot when traders are making outsized bets on Neumora Therapeutics Inc before the broader market catches on. Neumora Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor NMRA unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching NMRA unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking NMRA unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and NMRA unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer's disease; and NMRA-266, which is in the phase 1 clinical trial for the treatment of schizophrenia and other neuropsychiatric disorders.

In addition, its preclinical phase product includes NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson's disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.

Catalysts rarely arrive without a footprint, and NMRA unusual options activity is often where that footprint shows up first. Our scanner tracks Neumora Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at NMRA unusual options volume on the call side or chasing put sweeps, Neumora Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.